Morningstar Investor users sign in here.

Johann Scholtz

Johann Scholtz

is an equity analyst for Morningstar

UBS should benefit from Credit Suisse takeover
Stocks
UBS should benefit from Credit Suisse takeover
Credit Suisse shareholders will feel shortchanged, but salvaging at least something is the best outcome under current circumstances.  
Credit Suisse gets liquidity injection, but further restructuring needed
Stocks
Credit Suisse gets liquidity injection, but further restructuring needed
Under fire Swiss bank Credit Suisse, whose share price plunged 25% amid concerns over its financial health, has been thrown a lifeline by...